BISPECIFIC ANTI-CD20/ANTI-CD3 ANTIBODIES TO TREAT ACUTE LYMPHOBLASTIC LEUKEMIA

• 收藏
• 分享

专利权人:

REGENERON PHARMACEUTICALS; INC.

发明人:

BROWNSTEIN, CARRIE

申请号：

CA3009322

公开号：

CA3009322A1

申请日:

2016.12.21

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The present invention provides methods for treating, reducing the severity, or inhibiting the growth of acute lymphoblastic leukemia. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a bispecific antibody that specifically binds to CD20 and CD3.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/